Cargando…
Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy
SIMPLE SUMMARY: Patients with high-risk acute leukemias and lymphomas undergo stem cell transplantation or cellular therapies to achieve a cure. These are complex treatments that are typically offered by specialty medical centers. Patients are treated and monitored in the hospital for 3–4 weeks due...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452361/ https://www.ncbi.nlm.nih.gov/pubmed/37627136 http://dx.doi.org/10.3390/cancers15164108 |